Zusammenfassung

Die portale Hypertension wird definiert als eine Erhöhung der Pfortaderdrucks über 10–12 mmHg. Durch eine Erhöhung des Pfortaderdurchflusses bei gleichzeitiger Anhebung des portalen Gefäßwiderstandes kommt es zur Ausbildung einer portalen Hypertension, in deren Folge mit zahlreichen Komplikationen zu rechnen ist. Die dabei entstehenden Symptome der portalen Hypertension sind unmittelbar als Folge einer stattfindenden Druckentlastung des erhöhten portalen Drucks zu sehen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Bernard B, Lebrec D, Mathurin P et al. (1997) Beta adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: A meta-analysis. Hepatology 25: 63–70PubMedCrossRefGoogle Scholar
  2. Besson I, Ingrand P, Person B et al. (1995) Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med 333: 555–560PubMedCrossRefGoogle Scholar
  3. Boyer TD, Henderson JM (1996) Portal hypertension and bleeding esophagela varices. In: Zakim D, Boyer TD (eds) Hepatology. Saunders, Philadelphia, pp 720–763Google Scholar
  4. Carbera J, Maynar M, Granados R et al. (1996) Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment or variceal hemorrhage. Gastroenterology 110: 832–839CrossRefGoogle Scholar
  5. Feu F, Garcia-Pagan JC, Bosch J et al. (1995) Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorhage in patients with cirrhosis. Lancet 346: 1056–1059PubMedCrossRefGoogle Scholar
  6. Floras JS, Legault L, Morah GA et al. (1991) Increased sympathetic outflow in cirrhosis and ascites: direct evidence from intraneural recordings. Ann Intern Med 114: 373–380PubMedCrossRefGoogle Scholar
  7. Fox VL, Carr-Locke DL, Connors PJ, Leichtner AM (1995) Endoscopic ligation of esophageal varices in children. J Pediatr Gastroenterol Nutr 20: 202–208PubMedCrossRefGoogle Scholar
  8. Hayes PC, Davis JM, Lewis JA, Boucher IAD (1990) Meta-analysis of value of propanolol in prevention of variceal hemorrhage. Lancet 336: 153–156PubMedCrossRefGoogle Scholar
  9. Rossle M, Haag K, Ochs A et al. (1994) The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 330: 165–171PubMedCrossRefGoogle Scholar
  10. Schneider BL, Groszmann RJ (1994) Portal hypertension. In: Suchy FJ (ed) Liver disease in children. Mosby, St. Louis, pp 249–266Google Scholar
  11. Stanley AJ, Hayes PC (1997) Portal hypertension and variceal haemorrhage. Lancet 350: 1235–1239PubMedCrossRefGoogle Scholar
  12. Teran JC, Imperiale TF, Mullen KD et al. (1997) Primary prophylaxis of variceal bleeding in cirrhosis: A cost-effectiveness analysis. Gastroenterology 112: 473–482PubMedCrossRefGoogle Scholar
  13. Teres J, Bosch J, Bordas J et al. (1993) Propanolol versus sclerotherapy in preventing variceal rebleeding: a randomized controlled trial. Gastroenterology 105: 1508–1514PubMedCrossRefGoogle Scholar
  14. Vlavianos P, Gimson AES, Westaby D, Williams R (1989) Balloon tamponade for the management of variceal bleeding: uses and misuses. Br Med J 298: 1158CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • T. Lang

There are no affiliations available

Personalised recommendations